News

Imaging platform that illuminates residual breast cancer in real-time gets 'historic' FDA approval

LumiSystem enables surgeons to intraoperatively illuminate residual cancerous tissue in the breast cavity during lumpectomy surgery.

Even AI struggles to work under stress, study suggests

Apparently, it isn’t just humans who occasionally struggle to work under stress. According to a recent study, the performance of AI flounders, too.

microstructural differences present on diffusion tensor imaging of brains of individuals with ASD

Experts spot structural differences on brain imaging of individuals with autism

New research could offer further insight into exactly what causes individuals on the spectrum to process information differently.

Boston Scientific recalls premixed embolic agent after two deaths

There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.

chatgpt for patient questions about radiology

ChatGPT both passes and fails at translating free-text into structured reports

While the latest ChatGPT models show promise in easing the reporting burden on radiologists in the future, they aren't up to the task just yet.

Imaging agent that targets deadly brain tumors given FDA's Fast Track designation

Fast Track designations are typically granted to drugs that target an unmet medical need.

CT iodine contrast Omnipaq bolus next to a scanner at Central DuPage Hospital.

Should women pause breastfeeding after contrast injections? Survey reveals vastly different opinions

The recommendations differ between professional medical organizations and contrast manufacturers as well.

CT procedure shown to reduce need for invasive cardiac testing

In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.

With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have eluded that conservation efforts are of critical importance.#contrastshortage #CTcontrast #iodinatedcontrast

Omnipaque and Visipaque still listed among the FDA's drug shortages

According to the FDA’s most recent update, some presentations will remain out of stock or backordered until January 2023.

A study published this week in Radiology found that 12 months after hospitalization for COVID pneumonia, 93% of patients’ lung abnormalities had cleared up on follow-up chest CT scans.#covidpneumonia #groundglassopacities

Performance of RSNA's COVID-19 chest CT guidelines studied in vaccinated vs unvaccinated

True positive rates of COVID pneumonia on chest CT are significantly lower in patients who are vaccinated against the virus in comparison to their unvaccinated peers.

Internal symposium for breast imaging technologists is a hit among attendees

Of those who completed post-symposium surveys, 100% agreed that they would recommend the event to others who are looking to expand their knowledge of breast imaging.

Concerns about the future of AI are deterring students from pursuing radiology, survey shows

According to the new data, students believe that emerging technologies, including artificial intelligence, could eventually render some specialties obsolete.

Around the web

Cardiovascular Business

Boston Scientific recalls premixed embolic agent after two deaths

Cardiovascular Business

First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required

An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFR_CT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data.

Radiology Business

Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday.